NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 7 filers reported holding NLS PHARMACEUTICS LTD in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,900 | +0.3% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $6,880 | -38.7% | 200,000 | 0.0% | 0.00% | -62.5% |
| Q4 2023 | $11,220 | -46.7% | 200,000 | 0.0% | 0.01% | -27.3% |
| Q3 2023 | $21,040 | -1.7% | 200,000 | 0.0% | 0.01% | -31.2% |
| Q2 2023 | $21,400 | -28.7% | 200,000 | 0.0% | 0.02% | -5.9% |
| Q1 2023 | $30,000 | -21.1% | 200,000 | 0.0% | 0.02% | -10.5% |
| Q4 2022 | $38,010 | -11.6% | 200,000 | 0.0% | 0.02% | +18.8% |
| Q3 2022 | $43,000 | +79.2% | 200,000 | 0.0% | 0.02% | +60.0% |
| Q2 2022 | $24,000 | -68.4% | 200,000 | 0.0% | 0.01% | -60.0% |
| Q1 2022 | $76,000 | -47.9% | 200,000 | 0.0% | 0.02% | -37.5% |
| Q4 2021 | $146,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 200,000 | $11,220 | 0.01% |
| UBS Group AG | 1,000 | $55 | 0.00% |
| ARMISTICE CAPITAL, LLC | 500,000 | $28,050 | 0.00% |
| CLEAR STREET LLC | 8,500 | $0 | 0.00% |
| Hudson Bay Capital Management LP | 100,000 | $5,610 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |